These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21991837)

  • 21. Immunotherapy with glutaraldehyde treated tyrosine adsorbed grass pollen in the treatment of allergic rhinitis.
    Small P; Shapiro M
    Ann Allergy; 1981 Dec; 47(6):443-5. PubMed ID: 6798900
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hay fever: peroral desensitization as an additional measure].
    Harabacz I
    Fortschr Med; 1985 Aug; 103(30):62-3. PubMed ID: 4043905
    [No Abstract]   [Full Text] [Related]  

  • 23. Trichuris suis might be effective in treating allergic rhinitis.
    Summers RW; Elliott DE; Weinstock JV
    J Allergy Clin Immunol; 2010 Mar; 125(3):766-7. PubMed ID: 20153033
    [No Abstract]   [Full Text] [Related]  

  • 24. Upper respiratory tract infections and sublingual immunotherapy: preliminary evidence.
    Ciprandi G; Sormani MP; Cirillo I; Tosca M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):262-3. PubMed ID: 19354079
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
    Mösges R; Köberlein J; Keppler J
    MMW Fortschr Med; 2008 Jun; 150 Suppl 2():79-84. PubMed ID: 18712127
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunoglobulin therapy in IgE-mediated allergic diseases].
    Spornraft P; Ring J
    Hautarzt; 1991 Oct; 42(10):605-6. PubMed ID: 1757252
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hay fever. Immunoglobulin therapy in general practice].
    Fiesel H
    Fortschr Med; 1986 May; 104(19):397-400. PubMed ID: 3721377
    [No Abstract]   [Full Text] [Related]  

  • 28. Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils.
    Ciprandi G; Tosca MA
    Clin Exp Allergy; 2010 Sep; 40(9):1431-2; author reply 1432. PubMed ID: 20701617
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy control of hyposensitization treatment in inhalation allergies].
    Bauer CP
    Monatsschr Kinderheilkd; 1984 Jun; 132(6):488-93. PubMed ID: 6472296
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endonasal allergoid therapy of seasonal allergic rhinosinusitis].
    Giusan AO
    Vestn Otorinolaringol; 1985; (6):81-2. PubMed ID: 4090168
    [No Abstract]   [Full Text] [Related]  

  • 31. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 32. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates.
    Sieber J; De Geest S; Shah-Hosseini K; Mösges R
    Curr Med Res Opin; 2011 Apr; 27(4):855-61. PubMed ID: 21323505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of grass pollen-specific immunotherapy among grass pollen allergic rhinitis in the general population.
    Linneberg A; Bødtger U
    Allergy; 2007 Jul; 62(7):825-6. PubMed ID: 17573735
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintenance immunotherapy in ragweed hay fever. Booster injections at six week intervals.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy; 1971 May; 47(5):273-82. PubMed ID: 4102487
    [No Abstract]   [Full Text] [Related]  

  • 35. [What is reliable in hyposensitization of IgE-induced diseases? Indications, contraindications, results and side effects].
    Fuchs T
    Internist (Berl); 1991 Dec; 32(12):721-8. PubMed ID: 1783514
    [No Abstract]   [Full Text] [Related]  

  • 36. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 37. Attitude and knowledge of patients with asthma and allergic rhinitis who received allergen immunotherapy in Phramongkutklao Hospital.
    Sangasapaviliya A; Pholsuwanchai K
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S100-5. PubMed ID: 21280521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Allergic rhinitis. Treating symptoms or desensitization?].
    MMW Fortschr Med; 2003 Jan; 145(5):52. PubMed ID: 12619217
    [No Abstract]   [Full Text] [Related]  

  • 39. Sublingual immunotherapy.
    Corrigan C
    J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
    [No Abstract]   [Full Text] [Related]  

  • 40. Sublingual immunotherapy and regulatory T cells.
    Ciprandi G; Fenoglio D; Cirillo I; Milanese M; Minuti P
    Allergy; 2006 Apr; 61(4):511-3. PubMed ID: 16512819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.